Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NARATRIPTAN vs NAXITAMAB-GQGK: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NARATRIPTAN vs NAXITAMAB-GQGK: Safety Overview

Metric NARATRIPTAN NAXITAMAB-GQGK
Total FAERS Reports 526 152
Deaths Reported 9 2
Death Rate 1.7% 1.3%
Hospitalizations 102 56
Average Patient Age 49.2 yrs 7.5 yrs
% Female Patients 90.0% 53.4%
FDA Approval Date Apr 22, 2011 N/A
Manufacturer Hikma Pharmaceuticals USA Inc. N/A
Route ORAL N/A
Marketing Status Discontinued Prescription